| Objective: In the early years,foreign literatures have affirmed that transjugular intrahepatic portosystemic shunt(TIPS)can be applied for improving refractory ascites due to liver cirrhosis.However,compared with the present first-line treatment methods of ascites,now TIPS has avariety of complications such as hepatic encephalopathy after surgery an d poor survival improvement,so there is still disputes in the industry.In this paper,the preoperative related clinical indicators of thirty patient s with cirrhosis refractory ascites in our hospital were analyzed,aiming at exploring the best choice of TIPS for patients on the treatment of cirrhosis refractory ascites and providing treatment reference for patients with progress of different diseases in future clinical study.Methods: Thirty patients with cirrhosis refractory ascites treated by TIPS and complete treatment accompanied by follow-up in interventional radiology department of the First Affiliated Hospital of Xinjiang Medical University fro m January 2016 to January 2018 were collected.The diagnosis of all p atients was suitable for the diagnostic standard of the International Ascites Association for refractory ascites due to cirrhosis.Relevant clinical data of patients before surgery were adopted and their therapeutic effects were comprehensively analyzed.Results: Total bilirubin and serum cr eatinine are crucial factors for survival of patients with refractory ascite safter TIPS.The one year survival rate of patients with total bilirubin more than 44mmol/L was significantly lower than that of patients with total bilirubin less than 44mmol/L.And one year survival rate of patient s with serum creatinine more than 140mmol/L was significantly lower th an that of patients with serum creatinine less than 140 mmol/L.Conclu sion: Serum bilirubin and creatinine levels are significant clinical indica tors to evaluate the short-term survival of patients with cirrhosis-induce drefractory ascites after TIPS treatment. |
PDF Full Text Request